RAPAFLO

Physicians Total Care, Inc.🇺🇸 United States

FDA Page

Effective Date: Feb 15, 2012
Approval ID: 96425d91-cfe1-477d-a130-b58c330ca8a3
Products: 1 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

RAPAFLO® (silodosin) Capsules These highlights do not include all the information needed to use RAPAFLO® safely and effectively. See full prescribing information for RAPAFLO. RAPAFLO® (silodosin) capsule for oral useInitial U.S. Approval: 2008

Quick Stats

Total Products1

Labelers2

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.